Search

everythinglearnresearchcommunity

for

Search:↓

New tools help assess eyebrow, eyelash, and nail changes in Alopecia Areata, improving understanding of patient experiences.

New tools help doctors better assess and treat alopecia areata in kids by considering more than just hair loss.

Dexamethasone mini-pulse therapy is effective for alopecia areata but less effective for those with early onset or hypothyroidism.

Higher inflammation markers are linked to more severe alopecia areata.

Cyclosporine showed some improvement in alopecia areata but results were not statistically significant.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Fusion proteins can protect hair from heat damage.

Patients with certain baseline characteristics are more likely to benefit early from baricitinib for alopecia areata.

A new 6-point scale reliably measures heat damage to hair from styling tools.

Researchers created a new tool to measure the effects of alopecia areata from the patient's view, focusing on hair loss, daily life, and emotional health.

Weekly azathioprine pulse is a better alternative to corticosteroids for treating alopecia areata due to fewer side effects.

Bimatoprost may help treat hair loss from alopecia areata.

The EQ-5D-5L tool may not accurately measure the impact of alopecia areata on patients' lives.

Baricitinib effectively treats alopecia areata, with over half of patients improving after 52 weeks.

Baricitinib is a relatively safe and effective treatment for severe alopecia areata.

Mixing calcipotriol with a steroid is almost as effective as using a steroid alone for alopecia areata and has fewer side effects.

People with alopecia areata often have lower vitamin D levels, which may be linked to the condition's severity.

Centralized imaging provides more accurate and consistent hair loss measurements in alopecia areata.

Use specific tools to measure quality of life in alopecia areata patients and improve future treatments.

Practitioners treating hair loss need better education and resources to overcome challenges like commercial bias and ethical dilemmas.

The Cross-section Trichometer is a new tool that can measure hair quantity and detect hair loss and growth.

The AAPPO questionnaire is a reliable tool for assessing hair loss impact in alopecia areata patients.

The Cross-section Trichometer is a promising tool for measuring hair characteristics without cutting the hair and may have various clinical uses.

Baricitinib is a safe and effective treatment for alopecia areata, with better results in patients with lower initial severity, shorter disease duration, and longer treatment.

Tofacitinib effectively and safely promotes hair regrowth in alopecia patients.

A change in SALT scores of 42 or 43 indicates meaningful improvement in alopecia areata treatment.

Hypothyroidism is often linked to the hair loss condition telogen effluvium.

Baricitinib was effective and safe for severe hair loss treatment over 6 months.

Wharton's jelly-derived stem cells were safely used to treat four alopecia patients, resulting in hair regrowth in all of them.

Trichoscopy is a useful tool for diagnosing hair and scalp diseases without needing skin biopsies.